Morgan Stanley (NYSE:MS) analysts, led by Keith Weiss, adjusted the price target for Microsoft (NASDAQ:MSFT) shares, reducing ...

Morgan Stanley analysts were surprised by the response to DeepSeek's launch, a development that underscores the intense ...

On Wednesday, Microsoft ( MSFT, Financial) shares grew nearly 3% despite Morgan Stanley lowering their price target from $548 ...

Microsoft is set to report fiscal second-quarter earnings after the market closes Wednesday, with analysts largely bullish ...

Morgan Stanley analyst Joseph Moore lowered the firm’s price target on Micron (MU) to $91 from $98 and keeps an Equal Weight rating on the ...

AI is evolving rapidly with recent breakthroughs making it more accessible and efficient than ever. Smaller, cost-effective models are emerging, which are challenging the idea that cutting-edge AI ...

Investing.com -- Morgan Stanley lowered its price target for Nvidia (NASDAQ:NVDA) from $166 to $152 on Tuesday, citing investor concerns sparked by the release of DeepSeek’s AI model.

Morgan Stanley downgraded Astera Labs (ALAB) to Equal-weight from Overweight due to full valuation and priced-in product ...

Coverage and analysis of electric vehicle maker Tesla's fourth-quarter financial results, Q&A call, and the stock's reaction.

Astera Labs ( ALAB 0.63%) stock is sinking this week following new analyst coverage. The semiconductor specialist's share ...

Morgan Stanley (MS) stock saw a modest uptick, ending the day at $137.82 which represents a slight increase of $0.02 or 0.01% from the prior close of $137.8. The stock opened at $136.47 and touched a ...

Morgan Stanley lowered the firm’s price target on Ardent Health (ARDT) to $22 from $23.50 and keeps an Overweight rating on the shares after ...